glycosyltransferases form a functional multi-enzyme complex. Co-immunoprecipitation and gel filtration assays demonstrate that the Alg7p/Alg13p/Alg14p complex is a hexamer with a native molecular weight of ~200 kDa and a Alg7p:Alg13:Alg14p stoichiometry of 1:1:1. These results highlight and extend the striking parallels that exist between these eukaryotic UDP-GlcNAc transferases and their bacterial MraY and MurG homologues that catalyze the first two steps of the lipid-linked peptidoglycan precursor. In addition to their preferred substrate and lipid acceptors, these enzymes are similar in their structure, chemistry, temporal, and spatial organization. These similarities point to an evolutionary link between the early steps of N-linked glycosylation and those of peptidoglycan synthesis. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 The first two steps of LLO assembly form the chitobiose disaccharide "core" that consists of two GlcNAc residues attached to pyrophosphoryldolichol. It has been suggested that these first two steps are important regulatory sites that influence N-glycan substrate availability and thus flux through the glycosylation pathway (Lehrman 1991) but our understanding of the mechanisms that regulate these reactions are limited. The first GlcNAc is added by the GlcNAc 1-phosphate (P) transferase Alg7p (also known as GPT) that adds GlcNAc-1-P from UDPGlcNAc to produce GlcNAc-PP-dol (Lehrman 1991). Alg7p has multiple transmembrane Page 3 of 32 Glycobiology   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Mengin-Lecreulx et al. 1991; Mohammadi et al. 2007) to form the peptidoglycan precursor, GlcNAc-MurNAc-lipid. Remarkably, Alg13 and Alg14 are similar in sequence and predicted structure to MurG, which has a distinct two-domain structure (Ha et al. 2000). Alg13p
The first two steps of LLO assembly form the chitobiose disaccharide "core" that consists of two GlcNAc residues attached to pyrophosphoryldolichol. It has been suggested that these first two steps are important regulatory sites that influence N-glycan substrate availability and thus flux through the glycosylation pathway (Lehrman 1991) but our understanding of the mechanisms that regulate these reactions are limited. The first GlcNAc is added by the GlcNAc 1-phosphate (P) transferase Alg7p (also known as GPT) that adds GlcNAc-1-P from UDPGlcNAc to produce GlcNAc-PP-dol (Lehrman 1991) . Alg7p has multiple transmembrane F o r P e e r R e v i e w 4 spanning domains and a catalytic site that faces the cytosol (Dan and Lehrman 1997) . In the second step, the Alg13p/Alg14p UDP-GlcNAc transferase adds a second GlcNAc from UDPGlcNAc to produce GlcNAc2-PP-dol (Bickel et al. 2005; Chantret et al. 2005; Gao et al. 2005 ).
The Alg13p/Alg14p UDP-GlcNAc transferase is an unusual glycosyltransferase because it's catalytic and membrane-anchoring domains reside on two separate polypeptides. Alg13p is the soluble, cytosolic subunit that contains the catalytic domain; Alg14p is the membrane-spanning subunit that is required to recruit Alg13p to the cytosolic face of the ER (Averbeck et al. 2007; Bickel et al. 2005; Chantret et al. 2005; Gao et al. 2005) .
Unlike the other ER glycosyltransferases involved in LLO assembly, both Alg7p and Mengin-Lecreulx et al. 1991; Mohammadi et al. 2007 ) to form the peptidoglycan precursor, GlcNAc-MurNAc-lipid. Remarkably, Alg13 and Alg14 are similar in sequence and predicted structure to MurG, which has a distinct two-domain structure (Ha et al. 2000) . Alg13p
is homologous to the C-terminal catalytic domain of MurG, while Alg14p is homologous to the 2007; Bickel et al. 2005; Chantret et al. 2005; Gao et al. 2005 ).
Here, we provide evidence that like their bacterial counterparts, the eukaryotic Alg7p, Alg13p, and Alg14p UDP-GlcNAc transferases also physically interact to form a functional hetero-oligomeric glycosyltransferase complex. These results demonstrate that the parallels between the early steps of N-glycosylation and those of peptidoglycan synthesis extend beyond the sequence similarities of the prokaryotic and eukaryotic catalytic enzymes. The evolutionary conservation of these protein-protein interactions also provides new insights that may impact on the design of specific antibiotics that target the essential early steps of peptidoglycan synthesis.
RESULTS
Alg14p fractionates in a large protein complex -As a first step toward the biochemical characterization of the Alg13p/Alg14p UDP-GlcNAc hetero-oligomeric transferase, we investigated the native molecular weight of the Alg13p/ Alg14p complex using gel filtration chromatography. Previous studies demonstrated that the Alg13p/Alg14p complex remains stable in the presence of 0.1% Triton X-100 (Averbeck et al. 2007 ) so buffers containing 0.1% Triton were used to solubilize the Alg13p/Alg14p complex and during its fractionation over a Superose 12 column (see Experimental Procedures). These detergent extracts were prepared from a yeast strain that produces HA-tagged Alg14p. In this strain (XGY151), the normal ALG14 gene was replaced with a GAL1-promoter-driven HA-tagged ALG14 (Gao et al. 2005) . This strain grows normally in galactose-containing media, has no glycosylation defects, and grows in a manner that is indistinguishable from a wild type strain, demonstrating that HA-tagged Alg14p functions normally (Averbeck et al. 2007 ). After size fractionation, aliquots from each fraction were
Page 5 of 32 Glycobiology   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w   6 analyzed by SDS-PAGE and subjected to immunoblotting with anti-HA antibodies to identify fractions that contain HA-Alg14p. The predicted molecular weight of HA-Alg14p is ~ 30 kDa and that of Alg13p is ~ 23kDa. Therefore, if this complex was a simple hetero-dimer, we expected that Alg14p would co-fractionate with molecular weight markers of ~ 53 kDa.
However, the majority of HA-Alg14p (and Alg13p, see below) co-fractionated with molecular weight protein markers in the 160 ~ 200 kDa range (Figure 1 ). The leading edge of the Alg14p-containing fractions leaned towards the larger molecular weight markers (~200 kDa) and Alg14p
was not detectable in fractions containing the lower molecular weight markers. These results suggested that the native molecular weight of the Alg14p-containing oligomer is significantly larger than the predicted mass of the Alg13p/Alg14p dimer and that Alg14p exists in a large molecular weight complex.
Alg7 and Alg14 co-immunoprecipitate -The large size of the Alg14p-containing protein complex implied that it contains multiple copies of Alg14p and/or Alg13p, or that this complex contains additional components. Several observations prompted us to examine whether or not Alg7p associates with Alg14p. Hamster Alg7p/GPT has been reported to form oligomers (Dan and Lehrman 1997) , and also has a larger than expected native molecular weight (Shailubhai et al. 1988 ). Furthermore, a precedent exists for the idea that related ER glycosyltransferases function as hetero-oligomeric complexes: the Alg1, Alg2, and Alg11 mannosyltransferases that elongate GlcNAc 2 -PP-dol to Man 5 GlcNAc 2 -PP-dol on the cytosplasmic face of the ER do so as part of hetero-oligomeric enzyme complexes (Gao et al. 2004 ).
To explore the possibility that the related ER UDP-GlcNAc transferases (Alg7p, Alg14p, and Alg13p) also form hetero-oligomeric complexes as is seen by the Alg1, Alg2, and Alg11 mannosyltransferases, we performed experiments to determine if Alg14p interacts with Alg7p. Alg7 were assayed to ensure that these tagged alleles do not affect normal growth or glycosylation. We found that placing an epitope tag at the carboxyl terminus of Alg7p resulted in a non-functional protein (data not shown), a result that is consistent with earlier studies that showed the C-terminal domain of the hamster Alg7p is required for function (Zara and Lehrman 1994) . On the other hand, our results demonstrated that an N-terminal myc-tagged Alg7 is fully functional. The functionality of this N-terminal myc-Alg7p was assayed by complementation of the glycosylation defect and lethality that ensues from loss of ALG7 function (Figure 2A ). An ALG7/alg7∆ heterozygote (ALG7/alg7∆::kan R ) containing this plasmid-borne copy of ALG7 was sporulated and dissected. The kanamycin (G418)-resistant alg7∆ haploids harboring plasmidborne ALG7 were viable, grew with the same rate at their wild type sisters, and failed to grow on medium containing 5'-FOA ( Figure 2A ). This plasmid-borne myc-ALG7 allele also complemented the glycosylation defect of a conditional alg7 mutant strain (not shown).
Together, these results demonstrated that this plasmid-borne myc-ALG7 allele is functional. This ALG7 plasmid was thus used for the studies described below.
To determine if Alg7p interacts with Alg14p, we performed co-immunoprecipitation assays. Detergent extracts containing 0.1% Triton X-100, were prepared from strains that coexpress myc-ALG7 and HA-ALG14 (XGY151) to solubilize these membrane proteins. Alg7p
was precipitated with anti-myc antibody, precipitated proteins were resolved by SDS-PAGE, and subjected to immunoblotting with anti-HA antibody to detect HA-Alg14p. This experiment demonstrated that Alg14 did indeed co-precipitate with Alg7 ( Figure 2B , lane 1). Several control experiments demonstrated the specificity of this interaction. First, this interaction was antibody independent since the same result was observed with the opposite combination of 
Consistent with earlier findings that demonstrate the functional conservation between human
GPT and yeast Alg7p (Eckert et al. 1998), we found that hamster GPT completely complemented the lethality associated with loss of ALG7 ( Figure 3A ). If the interaction between Alg7p and pAlg14p is of functional relevance, then we expected to observe a physical interaction between hamster GPT and yeast Alg14. To test this, co-immunoprecipitation assays were performed.
Extracts from alg7∆ yeast strains that co-express HA-Alg14p and myc-hAlg7p were constructed (XGY151 +yEpGAP-myc-Alg7). Several non-ionic detergents, including digitonin, Triton X-100, Tween-20, and NP-40 were tested for their ability to solubilize Alg7p and Alg14p. Since the efficiency of co-precipitation of Alg7p and Alg14p was the same in all of these detergents (data not shown), further analyses used extracts prepared with Triton X-100. Detergent extracts prepared from each of these strains were fractionated in parallel with protein molecular weight markers on a Superose 12 column, using FPLC. Aliquots of fractions were assayed for the presence of HA-Alg14p, myc-Alg7p and HA-Alg13p by immunoblotting. The results from these experiments demonstrated that all three proteins co-eluted, with a peak position (fractions 9 and 10) that corresponds to a molecular weight of about 165-180 kDa ( Figure 4A and 4B). Based on fractionation behavior of these proteins on Superose, we can estimate that the vast majority of cellular Alg7 and Alg14 interact together, and that at least half of Alg13 co-fractionates in this Figure 4B ). Alg13p is a small soluble protein that exists in two pools. One pool is bound to the ER membrane through an association with Alg14p while the other pool is free in the cytosol (Averbeck et al. 2008; Bickel et al. 2005; Gao et al. 2005) . The fractionation behavior of Alg13p is consistent with the interpretation that the two elution peaks represent these two pools of Alg13p. The second peak of Alg13p fractionated with a molecular weight that is larger than the predicted monomeric molecular weight (~23), but smaller than the predicted dimeric molecular weight (46). We have not further investigated the oligomeric properties of the cytosolic (inactive) pool of Alg13p.
Nevertheless, taken together with the co-immunoprecipitation data described above, these results demonstrate Alg13p, Alg14p, and Alg7p co-fractionate with one another, and are consistent with the model that these proteins interact as part of an oligomeric complex.
Evidence for a hexameric UDP-GlcNAc transferase complex -The estimated molecular weight of the Alg14p, Alg13p and Alg7p complex by size chromatography is about 165-200 kDa. This size is significantly larger than the combined monomeric molecular weight of the three proteins, about 100 kDa. (The monomeric molecular weights of these proteins are: Alg13p = 22.6 kDa, Alg14p = 27 kDa, and Alg7p = 50.3 kDa). This discrepancy suggests that one or more of these proteins exists in more than one copy within the complex, or that the complex contains additional members. To determine if Alg13, Alg14 or Alg7 are present in more than one copy within the complex, we performed a series of co-immunoprecipitation assays using extracts from yeast that co-express myc-and HA-tagged alleles of each gene. The rationale behind this approach is Page 10 of 32 Glycobiology   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 F o r P e e r R e v i e w 11 based on the idea that co-immunoprecipitation of the myc-and HA-tagged protein, for instance HA-Alg14p and myc-Alg14p, is only possible by homo-oligomerization or by being bridged to itself through another member of the complex. To perform this experiment, yeast strains were constructed that co-express HA-Alg13p and myc-Alg13p, HA-Alg14p and myc-Alg14p, or HAAlg7p and myc-Alg7p. Detergent extracts were prepared as described above and subjected to co-immunoprecipitation assays. As controls, each experiment was carried out with antibodies in both directions, precipitating with either anti-HA or anti-myc and blotting for the corresponding partner. In addition, control co-precipitations were performed in parallel using strains that express only one of the tagged alleles. From these experiments, the following conclusions were reached. First, we found evidence for high affinity interactions between Alg14p and itself ( Figure 5A ), between Alg13p and itself ( Figure 5B) , and between Alg7p and itself ( Figure 5C ). myc-Alg14p quantitatively co-precipitated with HA-Alg14p, as was the case for myc-and HAAlg13p, and myc-and HA-Alg7p. These results imply that Alg7p, Alg13p, and Alg14p are each present in two or more copies in the complex. In contrast, by this assay we found only a very weak interaction between Alg13p and Alg7p ( Figure 5D ). Moreover, this weak interaction between Alg13p and Alg7p was detected only if Alg7p was immunoprecipitated but not vice versa. When the order of this reaction was reversed and Alg13p was immunoprecipitated, bound Alg7p was barely detectable ( Figure 5D ). One explanation for this result is that Alg7p and Alg13p are not directly in contact but rather associate weakly through their mutual interaction with Alg14p. Together with our gel filtration data that estimate a native molecular weight of the complex between 165-200 kDa, these co-immunoprecipitation results suggest a 2:2:2 stoichiometry of Alg7p:Alg14p:Alg13p in the complex, resulting in a combined predicted molecular weight of ~200 kDa. (Kean et al. 1999 ). An investigation of these proteins will be required to determine whether or not their oligomeric interactions contribute to their regulated activity.
The dolichol-linked glycosylation pathway is highly conserved among eukaryotes, so a strong prediction is that the Alg7/Alg13/Alg14 UDP-GlcNAc transferase complex is organized in mammals as it is in yeast. In support of this idea, we found that mammalian GPT and yeast Alg7p are functionally interchangeable and can partner equally well with yeast Alg14p (Eckert et al. 1998) despite their low sequence similarity. Two other pieces of data are consistent with the idea that the organization of the UDP-GlcNAc transferase complex has been conserved in mammals. First, mammalian GPT has a high native molecular weight (Dan and Lehrman 1997; Shailubhai et al. 1988) , suggesting that it homo-or hetero-oligomerizes. Second, elevated levels of GPT (Alg7p) cause a dominant negative phenotype in mammalian cells but this phenotype is independent of GPT catalytic activity (Gao et al. 2008 ). Instead, this phenotype appears to be caused by the competitive binding of GPT to a putative scaffold required for LLO biosynthesis (Gao et al. 2008) . Although speculative, our data are consistent with the idea that this scaffold may work through or be Alg14. Testing this idea will require a better characterization of the mammalian UDP-GlcNAc transferase enzymes.
A very important aspect of this study is that it provides a compelling argument for the idea that the lipid-linked cycles of peptidoglycan and N-linked glycoprotein synthesis have a common evolutionary origin. This idea, first described over ten years ago, was based on parallels between Alg7p and MraY (Bugg and Brandish 1994). Alg7p and MraY are both membrane proteins that are related in sequence, and that catalyze a chemically similar reaction.
Instead of UDP-GlcNAc, MraY transfers the structurally related phospho-MurNAc-pentapeptide to undecaprenyl-P, a polyisoprenoid lipid that is similar to dolichol-P. The recent identification Alg13/Alg14 and MurG are remarkably similar in structure.
As shown in this study, the eukaryotic Alg7/Alg13/Alg14 proteins physically interact in a membrane bound complex in the same way as their MraY/MurG bacterial counterparts (Mohammadi et al. 2007 ). Thus, the bacterial and eukaryotic enzymes are similar in structure, function, and organization. They sequentially catalyze similar chemical bonds, recognize structurally related polyprenyl lipid acceptors, and they associate with one another in a similar hetero-oligomeric membrane-associated protein complex. Together, these data provide the most compelling evidence for an evolutionary link between these two lipid-linked cycles. From a practical point of view, these data also provide an explanation for the longstanding puzzle of why many inhibitory drugs that target the MraY and MurG bacterial enzymes lack host cell specificity. This new knowledge will allow us to define the features that distinguish the eukaryotic and prokaryotic enzymes, and enable development of drugs that inhibit the latter.
Materials and Methods
Yeast strains and genetic methods -Standard yeast media and genetic techniques were used (Guthrie and Fink 1991) . Yeast strains were grown at 30°C in YPA (1% yeast extract, 2%
peptone, 50 mg/liter adenine sulfate) or in synthetic media that contained 0.67% yeast nitrogen All yeast strains were derived from W303-1A (MATa his3-11 leu2-3, 112 ura3-1 trp1-1   ade2-1 can1-100 ssd1-d) , W303-1B (MATα his3-11 leu2-3, 112 ura3-1 trp1-1 ade2-1 can1-100 ssd1-d), SEY6210 (MATα his3-11 trp1-1 lys2 leu2-3, 112 ura3-1 or GAP promoter. Careful analyses of all strains used in this study were conducted to ensure that these alleles are completely functional, localize correctly, and have no detrimental affect on glycosylation, cell wall biosynthesis or growth rates (C. Noffz, N. Averbeck, unpublished observation and see Results section).
Plasmids -Standard methods were used for all cloning. Fragments obtained by PCR and cloned into vectors were verified by DNA sequence analysis. The hamster ALG7/GPT cDNA was amplified by PCR, using pJB20-TRG22 as the template (Zhu and Lehrman 1990). pJB20-TRG22 contains the entire GPT cDNA and was kindly provided by Mark Lehrman. The yeast ALG7 gene was amplified by PCR from genomic DNA (from W303-1A). These amplified yeast and hamster (h) PCR products were cloned into yEp352GAP (Yoko-o et al. 1998 ) for expression as N-myc-tagged products in a URA3, 2µ yeast vector (yEp352GAP-myc-ALG7 and yEp352GAP-myc hALG7), or into yEp351 for production of an N-terminally tagged product in a LEU2, 2µ plasmid (yEp351GAP-HA-ALG7 and yEp351GAP-myc hALG7). Plasmid maps and primer sequences are available on request.
pRS306-HA-ALG14p contains P ALG14 -HA-ALG14 in the URA3 integration vector, pRS306 (Sikorski and Hieter 1989) . This plasmid was linearized by a partial NcoI digest to target its integration in the chromosomal ALG14 promoter.
Preparation of cell-free protein lysates -Exponentially growing cells (OD 600 of 1-3) were harvested and converted to spheroplasts with lyticase as described (Gao and Dean 2000) . 10 OD 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Cell debris and unlysed cells were removed by centrifugation at 14,000 g for 15 min at 4°C.
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These detergent lysates were used directly for immunoprecipitation or clarified by centrifugation at 100,00 g for 15 min for chromatography (see below). anti-Wbp1 antibodies as described previously (Gao and Dean 2000). To avoid cross reaction with the dissociated IgG heavy and light chains, whose molecular weights are very close to HAAlg13p (~26 kDa) and myc-Alg7p (~54 kDa), the combination of antibodies used in the immunoprecipitation and in Western analyses were derived from different animals. Primary antibodies were detected with secondary anti-rabbit or anti-mouse IgG conjugated to horseradish peroxidase, followed by chemiluminescence (ECL, GE Health Care, Inc.).
Co-immunoprecipitations and Western immunoblotting
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